MPM Oncology Impact Management »

Miragen Therapeutics shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.9M 255k 15.34
2023-06-30 $6.1M 255k 23.79

More positions owned by MPM Oncology Impact Management

Cullinan Oncology Common (CGEM)
Olema Pharmaceuticals Common (OLMA)
Geron Corporation Common (GERN)
Repare Therapeutics Common (RPTX)
iTeos Therapeutics Common (ITOS)
Intellia Therapeutics Common (NTLA)
Moonlake Immunotherapeutics Common (MLTX)
Iovance Biotherapeutics Common (IOVA)
Crinetics Pharmaceuticals Common (CRNX)
Insmed Incorporated Common (INSM)
Structure Therapeutics Common (GPCR)
Verve Therapeutics Common (VERV)
Relay Therapeutics Common (RLAY)
Regenxbio Common (RGNX)
Cymabay Therapeutics Common

View all positions for MPM Oncology Impact Management

Top funds holding Miragen Therapeutics

Paradigm Biocapital Advisors
VR Adviser
Vanguard Group
Maverick Capital
Alliancebernstein
Commodore Capital
Perceptive Advisors
Vivo Capital
Fairmount Funds Management
Yiheng Capital
Citadel Advisors
Tang Capital Management
Octagon Capital Advisors
Kynam Capital Management
Logos Global Management

View all funds holding Miragen Therapeutics